Diphtheria, tetanus, pertussis, Haemophilus influenzae b vaccine (CRM-197 adjuvant, Chiron)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameDiphtheria, tetanus, pertussis, Haemophilus influenzae b vaccine (CRM-197 adjuvant, Chiron)
Drug Alias NameQuattvaxem
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Biological material > Toxoid vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDiphtheriaHaemophilus InfectionsWhooping Cough
Global Approved IndicationsDiphtheriaHaemophilus InfectionsWhooping Cough
Approved Indications in ChinaN/A
Original Approved Country/TerritoryItaly
Original Approved Date2002/07/01
Country/TerritoryItalyMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesNovartis Vaccines
Active IndicationsDiphtheriaHaemophilus InfectionsWhooping Cough
Inactive IndicationsN/A

Other Information

ATC CodeJ07AG52
Related LinksN/A